Moderna Vaccine and Myocarditis: Important Comments from Health Canada

Canadian health officials stated on Friday that data indicate that rare cases of myocarditis were relatively higher following the administration of the Moderna COVID-19 vaccine compared to the Pfizer-BioNTech vaccine. The data also indicated that myocarditis occurs more frequently in teenagers and adults under the age of 30, and more often in males. A statement from the Public Health Agency of Canada noted that the majority of those affected experienced relatively mild symptoms and recovered quickly. The statement added that the risk of heart complications, including myocarditis, significantly increased after contracting COVID-19, according to reports from Reuters. The announcement from the Public Health Agency of Canada comes at a time when regulatory bodies in the United States, the European Union, and the World Health Organization continue to emphasize that the benefits of vaccination to prevent COVID-19 outweigh the risks.